venBio Partners is a leading life sciences investment firm that funds companies across various stages, from early to late-stage ventures. Their investment strategy includes leading most of their investments and building syndicates and teams. venBio's typical investment rounds include Series A, B, C, D, and E, with a strong focus on companies that have potential for significant impact in the life sciences sector.
Notable portfolio companies include Apellis Pharmaceuticals, Fog Pharmaceuticals, Harmony Biosciences, and Precision BioSciences. venBio's team brings extensive expertise in intellectual property, chemistry, manufacturing, clinical trial design, and regulatory considerations to help their portfolio companies succeed. Their investment philosophy emphasizes positioning companies for potential acquisition from the outset, ensuring they meet the rigorous requirements of potential acquirers.
venBio Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
